Renal Cell Carcinoma

Molecular Targets and Clinical Applications, Second Edition

Nonfiction, Health & Well Being, Medical, Specialties, Radiology & Nuclear Medicine, Oncology
Cover of the book Renal Cell Carcinoma by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781597453325
Publisher: Humana Press Publication: February 8, 2009
Imprint: Humana Language: English
Author:
ISBN: 9781597453325
Publisher: Humana Press
Publication: February 8, 2009
Imprint: Humana
Language: English

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

More books from Humana Press

Cover of the book Atlas of Human Pluripotent Stem Cells by
Cover of the book IVIG Therapy Today by
Cover of the book Biotargets of Cancer in Current Clinical Practice by
Cover of the book Clinical Pathology of Pancreatic Disorders by
Cover of the book Integrative Therapies in Lung Health and Sleep by
Cover of the book Tumor Models in Cancer Research by
Cover of the book Pathogenesis of Neurodegenerative Disorders by
Cover of the book Ocular Transporters in Ophthalmic Diseases and Drug Delivery by
Cover of the book Inflammatory Bowel Disease by
Cover of the book Drug Development by
Cover of the book Physician’s Guide to Terrorist Attack by
Cover of the book Voiding Dysfunction by
Cover of the book Vascular Disease and Injury by
Cover of the book The Best Guide to Allergy by
Cover of the book CyberForensics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy